Page last updated: 2024-08-21

arsenic trioxide and Leukemia, Prolymphocytic

arsenic trioxide has been researched along with Leukemia, Prolymphocytic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chopin, M; Dombret, H; Pierron, G; Poupon, J; Raffoux, E; RĂ©cher, C; Sigaux, F; Stern, MH1

Other Studies

1 other study(ies) available for arsenic trioxide and Leukemia, Prolymphocytic

ArticleYear
In vitro and in vivo effectiveness of arsenic trioxide against murine T-cell prolymphocytic leukaemia.
    British journal of haematology, 2002, Volume: 117, Issue:2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Ascorbic Acid; Leukemia, Prolymphocytic; Leukemia, T-Cell; Male; Mice; Mice, Transgenic; Models, Animal; Oxides; Proto-Oncogene Proteins; Survival Rate; Tumor Cells, Cultured

2002